UNHUnitedHealth Group Incorporated

Price: $388.18 | Today's Change: +2.77%

---

What Happened

UnitedHealth Group Incorporated filed an 8-K with the SEC on October 13, 2026, disclosing its Q2 FY2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The company reported revenues of $221.19 billion, net income of $9.70 billion, and diluted earnings per share of $10.61 for the quarter. Operating income came in at $14.27 billion, underscoring the scale and profitability of the company's diversified health insurance and services operations.

---

Why It Matters

For investors, this filing confirms that UnitedHealth Group continues to generate earnings at a substantial absolute scale, with a revenue base exceeding $221 billion in a single quarter. The diluted EPS of $10.61 and net income approaching $9.7 billion reflect a business still producing significant bottom-line results. The stock's +2.77% move on the day of this report suggests the market is responding positively to the disclosed figures. This follows StockWatch's initiating coverage published on October 9, 2026, meaning investors now have a concrete set of actual quarterly numbers to evaluate alongside that recently established analytical baseline.

Key figures at a glance:

• Revenues: $221.19 billion (Q2 FY2026)
• Operating Income: $14.27 billion (Q2 FY2026)
• Net Income: $9.70 billion (Q2 FY2026)
• Basic EPS: $10.66 (Q2 FY2026)
• Diluted EPS: $10.61 (Q2 FY2026)

---

Analysis

The sheer scale of UnitedHealth Group's Q2 revenues — over $221 billion — continues to reflect its position as one of the largest health services enterprises in the world by revenue. The operating income figure of $14.27 billion translates to an operating margin in the neighborhood of approximately 6.5%, which is characteristic of a company balancing very high-volume, lower-margin insurance operations with its higher-margin Optum health services segment.

The diluted EPS of $10.61, producing a net income figure of $9.70 billion, signals continued earnings power at an absolute level that few companies in any sector can match. Investors and analysts will be watching closely for any commentary in accompanying materials around medical loss ratios — a key driver of profitability in managed care — as well as forward guidance, which the structured XBRL data does not capture but which management may address in supplemental disclosures.

Given StockWatch's coverage was initiated just four days before this filing, the Q2 actuals now provide an important data point to measure against the framework established in that recent analysis. The market's positive reaction on the day is consistent with results that, at face value, demonstrate earnings resilience. What to watch next: any disclosed trends in care utilization costs, Optum segment performance, and management's forward outlook for the remainder of fiscal 2026.

---

Disclaimer

This report is a news and informational summary based solely on the official SEC filing data described above. It does not constitute investment advice, a solicitation to buy or sell any security, or an equity research rating of any kind. Past financial results are not necessarily indicative of future performance. Readers should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on UNH, published 2026-10-09. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-10-13. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/731766/000073176626000255/unh-20261013.htm